Skip to main content
. 2014 Jun 16;5(12):3983–3995. doi: 10.18632/oncotarget.2108

Table 3. Summary of TAPPS model development.

Results from multivariate Cox Proportional Hazards modeling for the full model (all pre-qualified markers entered into model) and the minimal model (markers rationally chosen from full model) with indicated Model P values. Provided are the marker in the model, multivariate HR, 95%CI, p-values and model coefficient (if applicable). Cox Proportional Hazard modeling results based on continuous TAPPS scores for both training set and validation set are provided for the full and minimal models.

Model Marker HR 95%CI P-value Coefficient
Full
(Individual Markers)
TEM1 Stroma 0.41 0.24-0.69 0.001 −0.89
TEM1 Tumor Vessel 3.27 1.35-7.95 0.009 1.19
HIF2α Stromal Vessel 0.47 0.25-0.88 0.02 −0.76
Collagen IV Tumor 1.86 1.08-3.21 0.03 0.62
FN Stroma 2.29 1.23-3.21 0.009 0.83
Full
(TAPPS Score)
TAPPS (Training)n=330 1.76 1.44-2.15 <0.001 NA
TAPPS (Validation)n=164 1.38 1.02-1.88 0.04 NA
TAPPS (w/Clinical)n=494 1.66 1.37-2.03 <0.001 NA
TAPPS (Stage II)n=126 1.75 1.22-2.52 0.002 NA
TAPPS (Stage III/IV)n=235 1.40 1.14-1.73 0.001 NA
Minimal
(Individual Markers)
TEM-1 Stroma 0.58 0.36-0.93 0.03 −0.55
Collagen IV Tumor 1.90 1.12-3.25 0.02 0.64
FN Stroma 2.18 1.18-4.05 0.01 0.78
Minimal
(TAPPS Score)
mTAPPS (Training)n=330 2.72 1.82-4.08 <0.001 NA
mTAPPS (Validation)n=164 2.66 1.26-5.62 0.01 NA
mTAPPS (w/Clinical)n=494 2.37 1.48-3.81 <0.001 NA
mTAPPS (Stage II)n=126 3.99 1.71-9.29 0.001 NA
mTAPPS (Stage III/IV)n=234 1.94 1.27-2.98 0.002 NA